These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24739633)

  • 1. Mucosal toll-like receptor 3-dependent synthesis of complement factor B and systemic complement activation in inflammatory bowel disease.
    Ostvik AE; Granlund Av; Gustafsson BI; Torp SH; Espevik T; Mollnes TE; Damås JK; Sandvik AK
    Inflamm Bowel Dis; 2014 Jun; 20(6):995-1003. PubMed ID: 24739633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Toll-like receptor-3 is enhanced in active inflammatory bowel disease and mediates the excessive release of lipocalin 2.
    Østvik AE; Granlund AV; Torp SH; Flatberg A; Beisvåg V; Waldum HL; Flo TH; Espevik T; Damås JK; Sandvik AK
    Clin Exp Immunol; 2013 Sep; 173(3):502-11. PubMed ID: 23668802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced expression of CXCL10 in inflammatory bowel disease: potential role of mucosal Toll-like receptor 3 stimulation.
    Ostvik AE; Granlund AV; Bugge M; Nilsen NJ; Torp SH; Waldum HL; Damås JK; Espevik T; Sandvik AK
    Inflamm Bowel Dis; 2013 Feb; 19(2):265-74. PubMed ID: 22685032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal Epithelial Cells Express Immunomodulatory ISG15 During Active Ulcerative Colitis and Crohn's Disease.
    Østvik AE; Svendsen TD; Granlund AVB; Doseth B; Skovdahl HK; Bakke I; Thorsvik S; Afroz W; Walaas GA; Mollnes TE; Gustafsson BI; Sandvik AK; Bruland T
    J Crohns Colitis; 2020 Jul; 14(7):920-934. PubMed ID: 32020185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of CCL20 and Its Corresponding Receptor CCR6 Is Enhanced in Active Inflammatory Bowel Disease, and TLR3 Mediates CCL20 Expression in Colonic Epithelial Cells.
    Skovdahl HK; Granlund Av; Østvik AE; Bruland T; Bakke I; Torp SH; Damås JK; Sandvik AK
    PLoS One; 2015; 10(11):e0141710. PubMed ID: 26536229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposite effects of interferon regulatory factor 1 and osteopontin on the apoptosis of epithelial cells induced by TNF-α in inflammatory bowel disease.
    Tang R; Yang G; Zhang S; Wu C; Chen M
    Inflamm Bowel Dis; 2014 Nov; 20(11):1950-61. PubMed ID: 25208103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of key regulators of Toll-like receptors in ulcerative colitis and Crohn's disease: a role for Tollip and peroxisome proliferator-activated receptor gamma?
    Fernandes P; MacSharry J; Darby T; Fanning A; Shanahan F; Houston A; Brint E
    Clin Exp Immunol; 2016 Mar; 183(3):358-68. PubMed ID: 26462859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The increased mucosal mRNA expressions of complement C3 and interleukin-17 in inflammatory bowel disease.
    Sugihara T; Kobori A; Imaeda H; Tsujikawa T; Amagase K; Takeuchi K; Fujiyama Y; Andoh A
    Clin Exp Immunol; 2010 Jun; 160(3):386-93. PubMed ID: 20089077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
    Griga T; May B; Pfisterer O; Müller KM; Brasch F
    Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease.
    Griga T; Voigt E; Gretzer B; Brasch F; May B
    Hepatogastroenterology; 1999; 46(26):920-3. PubMed ID: 10370639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A galectin-specific signature in the gut delineates Crohn's disease and ulcerative colitis from other human inflammatory intestinal disorders.
    Papa Gobbi R; De Francesco N; Bondar C; Muglia C; Chirdo F; Rumbo M; Rocca A; Toscano MA; Sambuelli A; Rabinovich GA; Docena GH
    Biofactors; 2016; 42(1):93-105. PubMed ID: 26891020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Toll-like receptor 9 and response to bacterial CpG oligodeoxynucleotides in human intestinal epithelium.
    Pedersen G; Andresen L; Matthiessen MW; Rask-Madsen J; Brynskov J
    Clin Exp Immunol; 2005 Aug; 141(2):298-306. PubMed ID: 15996194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface epithelium related activation of complement differs in Crohn's disease and ulcerative colitis.
    Halstensen TS; Mollnes TE; Garred P; Fausa O; Brandtzaeg P
    Gut; 1992 Jul; 33(7):902-8. PubMed ID: 1379568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-inflammatory effects of pancreatitis associated protein in inflammatory bowel disease.
    Gironella M; Iovanna JL; Sans M; Gil F; Peñalva M; Closa D; Miquel R; Piqué JM; Panés J
    Gut; 2005 Sep; 54(9):1244-53. PubMed ID: 15870231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of a splice variant of CXCR3 in Crohn's disease patients; indication for a lymphocyte--epithelial cell interaction.
    Manousou P; Kolios G; Drygiannakis I; Pyrovolaki K; Bourikas L; Papadaki HA; Kouroumalis E
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1823-33. PubMed ID: 18761554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and function of toll-like receptor 8 and Tollip in colonic epithelial cells from patients with inflammatory bowel disease.
    Steenholdt C; Andresen L; Pedersen G; Hansen A; Brynskov J
    Scand J Gastroenterol; 2009; 44(2):195-204. PubMed ID: 18985539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crohn's Disease Patients in Remission Display an Enhanced Intestinal IgM⁺ B Cell Count in Concert with a Strong Activation of the Intestinal Complement System.
    Preisker S; Brethack AK; Bokemeyer A; Bettenworth D; Sina C; Derer S
    Cells; 2019 Jan; 8(1):. PubMed ID: 30669641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of RANTES expression in Crohn's disease and ulcerative colitis: an aid in the differential diagnosis?
    Ansari N; Abdulla J; Zayyani N; Brahmi U; Taha S; Satir AA
    J Clin Pathol; 2006 Oct; 59(10):1066-72. PubMed ID: 16565224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of ATP-activated P2X7 receptors in the intestinal mucosa is implicated in the pathogenesis of Crohn's disease.
    Neves AR; Castelo-Branco MT; Figliuolo VR; Bernardazzi C; Buongusto F; Yoshimoto A; Nanini HF; Coutinho CM; Carneiro AJ; Coutinho-Silva R; de Souza HS
    Inflamm Bowel Dis; 2014 Mar; 20(3):444-57. PubMed ID: 24412990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation.
    Vivinus-Nébot M; Frin-Mathy G; Bzioueche H; Dainese R; Bernard G; Anty R; Filippi J; Saint-Paul MC; Tulic MK; Verhasselt V; Hébuterne X; Piche T
    Gut; 2014 May; 63(5):744-52. PubMed ID: 23878165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.